Across England the 15 AHSNs are working to deliver a national adoption and spread programme which aims to transform the diagnosis of attention deficit hyperactivity disorder (ADHD) across the region. In March 2022 the programme was awarded the HSJ Partnership Award for best mental health partnership.
What is the problem we’re addressing?
Attention deficit hyperactivity disorder (ADHD) is a behavioural disorder that includes symptoms such as inattentiveness, hyperactivity and impulsiveness and affects around 5% of school-aged children worldwide.
ADHD can have a large impact on personal, academic, family and social interaction.
In the UK children can wait on average 18 months from their first appointment to receiving a formal ADHD diagnosis and the annual cost of ADHD assessments to the NHS is estimated at around £23m.
In the NHS Long Term Plan there is a commitment to improve children and young people’s mental health services which includes reducing waiting times for specialist services and supporting children, young people and their families through the diagnostic process.
The Focus ADHD model
The Focus ADHD intervention uses technology created by health technology company Qbtech Ltd. The technology, QbTest, measures a patient’s attention, impulsivity and motor activity all at the same time. These indicators are core symptoms of ADHD and accurate measurement adds objectivity to support timely diagnosis.
The intervention has shown a reduction in time to diagnosis by 153 days (median). Using this intervention increases staff capacity by reducing the number of appointments needed for diagnosis and by ruling out ADHD sooner for ambiguous cases. Releasing capacity of clinicians can help reduce waiting lists and allow clinicians more time to concentrate on complex cases.
Find out more about the research and evaluation of QbTest with this short video from East Midlands AHSN who piloted the approach before it was selected as a national AHSN Network programme:
Patient case study
In our new case study hear from a parent, ADHD nurse and consultant as they discuss the journey to diagnosis for Tom and how he and his family benefited from the Focus ADHD programme and use of QbTest.
“QbTest enabled true, real-time insight into Tom’s difficulties with attention and concentration, and in particular how hyperkinetic he is. It gives objective evidence based on Tom’s performance. The test has enabled an ADHD diagnosis to be confirmed”.
Clinical case study
Join our Community of Practice: Innovation needs on neurodiversity pathways for children and young people
In January 2022 the South West and West of England AHSNs hosted the first Community of Practice (CoP) exploring innovation needs on the children and young people’s neurodiversity pathways. A third meeting was held in June 2022 with the next planned for 26 September. Find out more and book your place.
It’s an opportunity to share and learn with regional colleagues such as commissioners, service leads and clinicians.
More information and contact details
For further information on Focus ADHD in the West of England, or to join our community of practice, please contact Megan Kirbyshire, Senior Project Manager.